June 16, 2010 (San Antonio, Texas) — Gabapentin enacarbil (GEn) improves both objective and subjective sleep disturbance among patients with primary restless legs syndrome (RLS), according to a study ...
August 4, 2011 — A new study is the first long-term prospective trial of dopamine agonist therapy in restless legs syndrome (RLS). The study, funded by UCB BioSciences and Schwarz Pharma, ...
Restless Legs Syndrome (RLS), or Willis-Ekbom disease (WED) is one of the most common chronic sensorimotor neurological conditions encountered by clinicians. It occurs in 5% to 10% of the adult ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results